Welcome to our dedicated page for BOWHEAD SPECIALTY HLDGS SEC filings (Ticker: BOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Loss triangles, reserve roll-outs, and reinsurance treaties can make Bowhead Specialty Holdings Inc’s disclosures daunting. If you have ever searched line-by-line through a 300-page 10-K only to locate one casualty loss ratio, you know the challenge. Stock Titan’s AI-powered summaries turn that complexity into clarity, presenting the numbers that matter in seconds.
Whether you need the Bowhead Specialty Holdings Inc quarterly earnings report 10-Q filing to gauge premium growth, or you are tracking Bowhead Specialty Holdings Inc insider trading Form 4 transactions before renewal season, every document lands here the moment it hits EDGAR. Our platform tags each 8-K, proxy, or S-1, then explains it in plain language. Expect real-time alerts for Bowhead Specialty Holdings Inc Form 4 insider transactions real-time, concise highlights from the latest 10-K, and context around Bowhead Specialty Holdings Inc proxy statement executive compensation decisions.
Dig deeper into Bowhead’s underwriting engine: compare segment loss ratios across Casualty, Professional Liability, and Healthcare Liability, follow catastrophe exposure disclosed in 8-Ks, and see how executives align incentives via stock grants. Use cases abound—monitor executive stock sales, track reserve development, or simply get the Bowhead Specialty Holdings Inc annual report 10-K simplified. With AI-powered analysis, comprehensive coverage, and real-time updates, understanding Bowhead Specialty Holdings Inc SEC documents has never been easier.
Matthew Botein, a director and reported 10% owner of Bowhead Specialty Holdings Inc. (BOW), sold 2,000,000 shares of the issuer's common stock at $30.66 per share in connection with an underwritten public offering on 08/08/2025. The filing reports that following the transaction the Reporting Person is associated with indirect beneficial ownership of 8,968,445 shares through GPC Partners Investments (SPV III) LP, while disclaiming beneficial ownership of those shares except to the extent of any pecuniary interest.
The footnotes disclose that Gallatin Point Capital entities manage the GPC vehicle and that a Voting Agreement links GPC Fund and American Family Mutual Insurance Company, S.I., which may be deemed a group for purposes of voting and investment decisions.
Gallatin Point Capital LLC and affiliated reporting persons disclosed an insider sale of Bowhead Specialty Holdings Inc. (BOW) common stock on 08/08/2025. The filing reports shares were sold in connection with an underwritten public offering at a price of $30.66 per share. The report lists a disposition of 2,000,000 shares and shows indirect beneficial ownership of 8,968,445 shares following the transaction. The sellers are reported as Gallatin Point Capital LLC, GPC Partners GP LLC, GPC Partners Investments (SPV III) LP, and Lewis A. (Lee) Sachs.
The filing explains the ownership chain: Gallatin Point manages GPC Partners GP LLC, which is general partner of the GPC Fund, and Matthew Botein and Lewis Sachs collectively make voting and investment decisions for the fund. The GPC Fund has a Voting Agreement dated May 22, 2024 with American Family Mutual Insurance Company, S.I., and the reporting persons disclaim beneficial ownership of shares owned by AFMIC to the extent applicable. Matthew Botein is deputized to represent the reporting persons on the Issuer's board.
Bowhead Specialty Holdings completed a registered public secondary offering of 2,000,000 shares of common stock sold by a selling stockholder, producing approximately $61,300,000 in gross proceeds to that stockholder. The company did not receive any proceeds from the sale. The transaction was executed under an Underwriting Agreement and the agreement is filed as an exhibit to the report.
The company previously maintained a registration statement on Form S-3 supplemented by a prospectus supplement in connection with the offering. Exhibits include the Underwriting Agreement and the cover page XBRL tags.